VANCOUVER, Wash., Oct. 06, 2020 (GLOBE NEWSWIRE) -- ORCHID VENTURES, INC. (CSE: ORCD OTC: ORVRF) (the “Company” or “Orchid”), a multi-state cannabis innovation company, is pleased to announce that it’s hardware manufacturing subsidiary, PurTec Delivery Systems, has finalized development and testing on two new products; a disposable vape, and the most stringently tested value cartridge in the market. Both products have been through leach testing, which determines if any toxic materials or heavy metals leach into the oil put into the cart, as well as PurTec’s industry leading AFNOR standards emissions testing. An emissions test evaluates the actual vapor exiting the hardware, which is what consumers inhale.
“Our focus is to design and engineer the highest quality vaporizer products in the industry for all spectrums of the market, from value to high-end. We believe that all levels of the market should have access to safe, tested, and reliable products for their consumers, and we have made it our mission to deliver this. No longer is there a reason or excuse to purchase untested, unsafe, and unreliable hardware for the CBD and cannabis market. The newest round of products is a representation of that mission,” said Luke Hemphill, Chief Revenue Officer of Orchid Ventures. “The demand we’ve seen for emissions tested products, as well as disposable products emulating the trends we see in the nicotine industry has been fuel for our development. Our new slimline PurCore Silo we believe to be the new standard of disposable vapes. These two new product lines are now available to customers worldwide.”
ABOUT ORCHID ESSENTIALS
Orchid Essentials is an Irvine, CA-based cannabis innovation company, that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium cannabis products and unique vape hardware delivery system. Since July 2019, Orchid has diversified its efforts and has brought to market innovative services and product offerings to support brands throughout the global cannabis industry. Orchid has diversified its portfolio to include PurTec Delivery Systems, a company that produces, markets and sells clean vaporizer hardware that has been emissions tested against the most stringent standards in the world set forth by the EU and has unrivaled product quality and value pricing. Orchid, through its wholly owned subsidiary, has launched a patented and clinically proven bioavailability solution to increase the absorption of THC and other cannabinoids making products much more effective and an activation time of less than ten minutes. With a continued focus on brand and intellectual property development, Orchid will continue to create new and innovative products and technologies, then bring them to the global cannabis marketplace and set the gold standard for delivery systems whether it’s vape or formulation sciences. Orchid's management brings significant branding, product development and distribution experience with a proven track record of scaling businesses and building sustainable revenue growth through value-generating partnerships and innovation that creates enterprise value. Learn more at https://orchidessentials.com/
ON BEHALF OF THE BOARD OF DIRECTORS – ORCHID VENTURES, INC.
Corey Mangold CEO and Director investors@orchidessentials.com
Investor Relations Corey Mangold 949-357-5818 corey@orchidessentials.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
#Cannabis #Vapes #CannabisAccessories #CannabisProducts #CannabisMarket #Cannabinoids #THC #CBD #CBDProducts #CannabisResearch #CannabinoidResearch #CBDResearch #EndocannabinoidMedicine #PotStocks #Cannabiz #CannabisMarket #CannabisStocks #Patents #PatentTechnology #CannabisTechnology #SmallCapStocks #FrontierMCG